ADHESTOP 25000IU INJECTION

Common side effects of ADHESTOP 25000IU INJECTION may include bruising, hematomas, pain at the injection site, and elevated liver enzymes. Serious side effects can include bleeding, Heparin-induced thrombocytopenia (HIT), hypersensitivity reactions, and osteoporosis.

ADHESTOP 25000IU INJECTION is generally considered safe during pregnancy and breastfeeding. It does not cross the placenta significantly and is not expected to harm the baby when used appropriately. However, its use should be under the guidance of a healthcare provider.

ADHESTOP 25000IU INJECTION dosing varies based on the patient's weight, medical condition, and desired anticoagulant effect. The dosage is usually adjusted based on regular monitoring of blood clotting parameters, such as activated partial thromboplastin time (aPTT) or anti-Xa assay.

Yes, ADHESTOP 25000IU INJECTION increases the risk of bleeding. Patients should be closely monitored for signs of bleeding and inform their healthcare provider promptly if they experience any unusual bleeding or bruising

ADHESTOP 25000IU INJECTION can be used in children and the elderly. However, special consideration is required in these populations due to differences in dosing and potential age-related factors that may affect its use.

There are no known significant negative interactions of ADHESTOP 25000IU INJECTION with other drugs.

Patients should inform their healthcare providers about their medical history, including any bleeding disorders, liver or kidney problems, recent surgeries, and allergies, to determine the appropriate dosage and administration method. Regular monitoring of blood clotting parameters, such as activated partial thromboplastin time (aPTT) or anti-Xa assay, is crucial to maintain the desired anticoagulant effect and prevent bleeding or thrombosis. Patients should follow the prescribed dosage and administration instructions precisely and report any unusual bleeding, bruising, or allergic reactions promptly. It is advisable to avoid activities or medications that may increase the risk of bleeding while on ADHESTOP 25000IU INJECTION. By adhering to these instructions and maintaining open communication with healthcare providers, patients can minimize risks and maximize the benefits of this therapy.

ADHESTOP 25000IU INJECTION is made of HEPARIN molecule/combination.

ADHESTOP 25000IU INJECTION acts as an anticoagulant, aiding in the management of cardiology related conditions.